The disabled dendritic cell

FASEB Journal

Volumn 15, Issue 6, 2001, Pages 1054-1061

  Thurnher, Martin ^a   Zelle Rieser, Claudia ^a   Ramoner, Reinhold ^a   Bartsch, Georg ^a   Höltl, Lorenz ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Eicosanoids; Interleukin 4; Phospholipase A2; Platelet activating factor

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ICOSANOID; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; LIPOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; T LYMPHOCYTE RECEPTOR; THROMBOCYTE ACTIVATING FACTOR;

ANTIGEN PRESENTING CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL;

ANTIGEN-PRESENTING CELLS; ARACHIDONIC ACID; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION;

EID: 0035067386     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0508hyp     Document Type: Article

References (65)

1. Dendritic cells and the control of immunity
2. Reciprocal control of T helper cell and dendritic cell differentiation
3. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo
4. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
5. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
6. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
7. Distinct patterns and kinetics of chemokine production regulate dendritic cell function
8. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
9. Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease
10. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
11. + blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer
12. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
13. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
14. Migration of human dendritic cells after injection in patients with metastatic malignancies
15. Lipid mediator networks in cell signaling: Update and impact of cytokines
16. Regulation and inhibition of phospholipase A2
17. Cyclooxygenases 1 and 2
18. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators
19. 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: Dual specificity, of 5-lipoxygenase towards endogenous and exogenous precursors
20. Platelet-activating factor: The biosynthetic and catabolic enzymes
21. Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells
22. Interleukin-4, transforming growth factor beta 1, and dexamethasone inhibit superantigen-induced prostaglandin E2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2
23. cPLA2 is phosphorylated and activated by MAP kinase
24. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes
25. Interleukin-4 inhibits the gene expression and biosynthesis of cytosolic phospholipase A2 in lipopolysaccharide stimulated U937 macrophage cell line and freshly prepared adherent rheumatoid synovial cells
26. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin 12 production
27. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
28. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-1ipoxygenase-activating protein (FLAP) in human neutrophils
29. Granulocyte-macrophage colony-stimulating factor upregulates reduced 5-1ipoxygenase metabolism in peripheral blood monocytes and neutrophils in acquired immunodeficiency syndrome
30. Specific inflammatory cytokines regulate the expression of human monocyte 15-1ipoxygenase
31. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release
32. Transforming growth factor beta 1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells
33. Transforming growth factor beta upregulates 5-1ipoxygenase activity during myeloid cell maturation
34. Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils
35. Immature dendritic cells phagocytose apoptotic cells via ανβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
36. The induction of tolerance by dendritic cells that have captured apoptotic cells
37. Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages
38. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
39. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein
40. 5-Lipoxygenase expression in Langerhans cells of normal human epidermis
41. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells
42. Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development
43. + T lymphoblasts
44. Prostaglandin E2 inhibits T cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction
45. A new view of prostaglandin E regulation of the immune response
46. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
47. Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines
48. Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: A possible mechanism to polarize Th2 type response in BALB/c mice
49. Mature dendritic cells induce T helper type 1-dominant immune responses in patients with metastatic renal cell carcinoma
50. + T cells in the antitumor immune response
51. T helper cell type 1-associated and cytotoxic T lymphocytes-mediated tumor immunity is impaired in interleukin 4-deficient mice
52. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4
53. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase
54. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells
55. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes
56. Leukotriene B4 enhances activation, proliferation, and differentiation of human B lymphocytes
57. Involvement of phospholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells
58. Role of lipoxygenation in human natural killer cell activation
59. Augmentation of human natural cytotoxic cell activity by leukotriene B4 mediated by enhanced effector-target cell binding and increased lytic efficiency
60. +, protein kinase C, and lipoxygenase products
61. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
62. IL-13 in allergy: Home at last
63. IL-13 increases the cPLA2 gene and protein expression and the mobilization of arachidonic acid during an inflammatory process in mouse peritoneal macrophages
64. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
65. Signal transduction by interferon-alpha through arachidonic acid metabolism